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Abstract
Imipenem-susceptible E. aerogenes isolates exhibiting extended spectrum b-lactamases, target mutations and a basal efﬂux expression,
were identiﬁed in ﬁve patients. After imipenem treatment, imipenem-intermediate susceptible (IMI-I) or resistant (IMI-R) isolates
emerged in these patients. Alteration in porin synthesis and increase in efﬂux expression were observed in the IMI-I isolates whereas
complete loss of the porins, LPS alteration and efﬂux overexpression were observed in the IMI-R isolates. Bacterial virulence of the
strains was investigated by the Caenorhabditis elegans model. The IMI-R isolates were shown to be signiﬁcantly less virulent than the IMI-
susceptible or IMI-I isolates. The pleiotropic membrane alteration and its associated ﬁtness burden exhibited by E. aerogenes isolates
inﬂuence their antibiotic resistance and their virulence behaviour. These ﬁndings highlight the balance between the low permeability-
related resistance and virulence and their relationships with the treatment of resistant pathogens.
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Introduction
Enterobacter aerogenes has been reported since the 1990s as
being increasingly resistant to various antibiotic families,
resulting in multidrug-resistant (MDR) isolates [1]. The
mechanism of resistance to b-lactams mostly consists of
enzymatic degradation by the chromosomal cephalosporinase
and plasmid-mediated broad spectrum b-lactamases [2]. The
mechanical barrier, via the change of membrane permeability
and efﬂux pump expression, also contributes to the
increased level of resistance to b-lactams, including carbapen-
ems, and to other antibiotic families (ﬂuoroquinolones and
chloramphenicol) [1,3,4].
After treatment including imipenem, the collected E. aeroge-
nes isolates were devoid of porin and resistant to b-lactams.
When the antibiotic treatment was removed, the imipenem
susceptibility and the expression of porins were recovered
[5,6]. This suggests the involvement of a regulator controlling
their expression and a pivotal role of these outer membrane
proteins in bacterial survival in the patient body, as recently
mentioned for Salmonella enterica, Klebsiella pneumoniae and
Escherichia coli strains [1,3,4]. Consequently, the modiﬁcation
of outer membrane permeability might have some adverse
effect on the ﬁtness and virulence level in these MDR clinical
isolates. Very few internal porin mutations altering the func-
tion of the channel have been reported in clinical isolates of
Enterobacteriaceae, suggesting that the alteration of porin might
seriously disadvantage bacterial ﬁtness [4]. Several studies
reported the involvement of enterobacterial membrane trans-
porters, including porins and efﬂux pumps, in modulating
different processes related to colonization/virulence and
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bacterial adaptation to host conditions [7–12]. This raises the
question of the cost of the accumulation of membrane-associ-
ated resistance mechanisms for bacterial ﬁtness during anti-
biotic chemotherapy and its consequence for bacterial
capacity during the colonization process.
The aim of this work was (i) to characterize the dynamic
and the impact of the membrane modiﬁcations in imipenem-
resistant strains isolated during antibiotic treatment of infec-
tion caused by original susceptible E. aerogenes strains, (ii) to
evaluate the potential virulence of these strains in the Ca-
enorhabditis elegans model and (iii) to evaluate a possible link
between the cost associated with the involved resistance
mechanisms and the bacterial adaptation and virulence.
Materials and Methods
Bacterial collection
A prospective surveillance programme for resistant bacteria
was initiated in Nıˆmes University Hospital. All E. aerogenes
resistant to broad-spectrum cephalosporins (BSC) were
selected. Specimens were regularly sampled from patients har-
bouring these strains to detect the emergence of imipenem-
resistant (IMI-R) isolates during the period following the start
of the imipenem treatment. If an intermediate susceptible (IMI-
I) or an IMI-R isolate was identiﬁed, the strain was stocked.
Bacteria identiﬁcation and antimicrobial susceptibility
testing
The genus and species were determined biochemically with
the Vitek 2-AST N017 identiﬁcation card (bioMe´rieux,
Marcy-l’Etoile, France). Antibiotic susceptibility was tested by
using the Vitek 2 GNS-F7 card (bioMe´rieux).
MICs of imipenem, cefepime, chloramphenicol, oﬂoxacin,
tetracycline and polymyxin B were determined by a standard
broth dilution method in triplicate [6,13]. The efﬂux pump
inhibitor phenylalanyl arginine b-naphthylamide (PAbN)
(Sigma-Aldrich, St-Quentin Fallavier, France) was used at
26.3 mg/L, for which no intrinsic effect has been observed
[14]. EDTA (0.5 mM) was used to evaluate the involvement
of outer membrane alteration in the polymyxin B resistance
[3,15,16]. E. aerogenes strain ATCC 13048 and EA27 clinical
isolate, which overexpressed the AcrAB efﬂux system, were
used as controls [6,17]. Isolates were classiﬁed as suscepti-
ble, intermediate susceptible or resistant to the antibiotics
according to the recommendations of the Antibiotic
Susceptibility Testing Committee of the French Society for
Microbiology (http://www.sfm.asso.fr/nouv/general.php?pa=2).
Enzymatic production was checked by the double-disk syn-
ergy test using MH agar with 250 mg/L cloxacillin (http://
www.eucast.org/clinical_breakpoints/). AmpC hyperproduc-
tion was evaluated by measuring MICs of ceftazidime, cefe-
pime and imipenem with the E-test method using MH agar
without and with 250 mg/L cloxacillin.
Characterization of b-lactamase-encoding genes and
ﬂuoroquinolone resistance
The blaTEM gene was detected by PCR and identiﬁed by
sequencing the PCR products as previously reported [18].
gyrA, gyrB, parC, parE, qnrA, qnrB and qnrS were screened by
PCR and PCR products were sequenced to detect mutations
as previously described [19].
PFGE analysis
Macrorestriction analysis of chromosomal DNAwas performed
using PFGE according to published procedures after XbaI
restriction (New England Biolabs France, Evry, France) using the
CHEF system (Bio-Rad SA, Ivry-sur-Seine, France) [20]. The
PFGE patterns were analysed with Gel compar computer soft-
ware (Applied Math, Kortrijk, Belgium) and an unweighted-pair
group method with the Dice coefﬁcient of similarity. Isolates
were considered to be within a cluster if the coefﬁcient of simi-
larity was >80%. The different isolates were compared with the
EAIA strain belonging to the French E. aerogenes clone [20].
SDS-polyacrylamide gel electrophoresis and outer
membrane proteins identiﬁcation
Exponential-phase bacteria in LB broth were pelleted and solu-
bilized [6,9]. Samples (bacterial amount corresponding to 0.02
optical density units at 600 nm) were loaded onto SDS-poly-
acrylamide gels (10%, 14% polyacrylamide, 0.1% SDS), then
electrotransferred to nitrocellulose membranes. The immuno-
detections were carried out as previously described with poly-
clonal antibodies directed against outer membrane proteins
(Omp35, Omp36, OmpX and OmpA) and against the efﬂux
pump components (AcrA and TolC) [13,21]. E aerogenes strains
ATCC 13048, EAEP289 (a derivative of strain EA27 exhibiting
norﬂoxacin efﬂux), EAEP294 and EAEP298 (EAEP289 acrA or
tolC derivatives, respectively) were used as controls.
The method for extracting outer membranes was
described previously [22]. The band corresponding to a new
major protein was excised from the SDS-polyacrylamide gels
and sequenced by mass spectrometry. Determination of the
degrees of identity and similarity with known proteins was
carried out using BLASTX and BLASTP and FASTA from the
Genetics Computer Group (GCG, Princeton, NJ, USA) [23].
Detection of high-pathogenicity island (HPI)
The presence of the HPI was determined by PCR analysis as
previously described [24].
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Nematode killing assay
The C. elegans model has been developed to study host-path-
ogen interactions and to identify the basic pathways well
conserved during evolution that are linked to microbial path-
ogenesis. In this test, the studied bacteria are presented as
food to the nematodes instead of E. coli strain OP50, an avir-
ulent strain, which is their usual food in the laboratory.
Ingestion of the bacteria by the worms results in an infection
and ultimately death of the worms. The time required by the
studied bacteria to kill the worms compared with the life
duration observed when the worms are fed with E. coli strain
OP50, is an indirect marker of virulence potential of the bac-
teria. The C. elegans infection assay was carried out by using
the Fer-15 mutant line as previously published [25]. At least
two replicates repeated six times were performed for each
selected clone. Lethal time 50% (LT50) and lethal time 100%
(LT100) corresponded to time (in days) required to kill 50%
and 100% of the nematode population, respectively. E. aerog-
enes strains ATCC13048 and CM64 (exhibiting an active
efﬂux) were used as reference.
The number of bacteria within the C. elegans digestive
tract was obtained as previously described [25]. C. elegans
were picked at 72 h, and the surface bacteria were removed
by washing the worms twice in 4 lL drops of M9 medium
on a BHI agar plate containing 25 mg/L gentamicin. The nem-
atodes were placed in a 1.5-mL Eppendorf tube containing
20 lL of M9 medium with 1% Triton X-100 and were
mechanically disrupted. The volume was 50 lL (M9 medium
containing 1% Triton X-100), which was diluted and plated
on BHI agar containing 50 mg/L ampicillin. Three replicates
were performed for each bacterial combination.
To compare the entire survival curves in nematode killing
assays, Cox regression was used. To perform pairwise com-
parison between two different strains, we used a log rank
test. The analysis was carried out using SPSS 6.1.1 (SPSS Inc.,
Chicago, IL, USA).
Results
Strains and antibiotic susceptibility
During the studied period (2 years), ﬁve patients (A–E) pre-
sented imipenem-susceptible E. aerogenes strains, then inter-
mediate or resistant (I or R) isolates. The strains exhibited
PFGE proﬁles with more than 90% similarity between each
other and with strain EAIA corresponding to the French
E. aerogenes clone (data not shown). The isolates IMI-S, IMI-I
or/and IMI-R from a given patient presented an identical pro-
ﬁle (100% similarity, data not shown).
The antibiotic susceptibilities are presented in Table 1.
Among the IMI-S isolates (S), all were resistant to cefepime,
chloramphenicol and oﬂoxacin, and 4/5 to tetracycline. No
isolate was resistant to polymyxin B. For IMI-I and IMI-R iso-
lates, the distribution of resistance percentages was quite
similar to those of IMI-S except for polymyxin.
The PAbN addition reduced the MICs for oﬂoxacin and
chloramphenicol in all strains (Table 1). Regarding tetra-
TABLE 1. Antibiotic susceptibilities of E. aerogenes isolates to different antibiotics with or without efﬂux pump inhibitor or
EDTA. For each patient, the ﬁrst isolate corresponds to the susceptible strain isolated before IMI treatment and the others
correspond to the intermediate- and resistance-IMI strains
Patient Strains
MIC (mg/mL) (with efﬂux pump inhibitora) [with EDTAb]
CHL TET OFL IMI FEP PMB
A NEA39541S >512 (64) 64 (32) 64 (16) £0.25 (£0.25) 32 (32) 0.5
NEA354871I 512 (64) 128 (32) 64 (16) 8 (4) >32 (32) 0.5
B NEA567234S 32 (£4) £2 (£1) 32 (2) 2 (0.5) 8 (4) 1
NEA575169I 128 (64) 16 (8) 32 (2) 4 (0.25) 8 (8) 1
C NEA31004S 512 (64) 8 (8) 64 (8) 1 (0.25) 32 (32) 1
NEA23214R >512 (64) 8 (8) 64 (8) 32 (8) >32 (>32) 2
D NEA48271S 512 (64) 8 (8) 128 (8) 1 (0.5) 32 (32) 1
NEA51351I 256 (64) 2 (1) 64 (8) 4 (0.25) 32 (32) 1
E NEA43735R 512 (64) 4 (4) 64 (16) 16 (0.25) >32 (32) 2
NEA709472S 32 (32) 128 (£1) £4 (£2) 0.5 (0.25) 32 (32) 1
NEA734521I 512 (64) 128 (32) 64 (4) 8 (2) 32(32) 1
NEA736500BCR 512 (16) 128 (8) 128 (8) 16 (4) 32 (16) 2
NEA736500SCR 256 (64) 128 (8) 64 (4) 32 (4) 64 (32) 128 [2]
Reference strains ATCC13048 4 (2) £4 £4 1 £8 1
EA27 512 (64) 8 128 8 >32 nd
CHL, chloramphenicol; TET, tetracyclines; OFL, oﬂoxacin; IMI, imipenem; FEP, cefepime; PMB, polymyxin B; S, susceptible to imipenem; I, intermediately susceptible to imipe-
nem; R, resistant to imipenem.
NEA736500BCR is an isolate with normal growth (BC, big colonies) and NEA736500SCR is an isolate with slow growth (SC, small colonies).
aPABN used at 26.3 mg/L.
bEDTA used at 0.5 mM.
cATCC 13048 strain with a normal level of AcrAB efﬂux system; EA27, clinical isolate with an over-expression of AcrAB efﬂux system.
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cycline susceptibility, the patient E isolates were strongly
sensitized by PAbN. One isolate (NEA736500SCR) was resis-
tant to polymyxin B. In the presence of EDTA, which che-
lates polycations associated with LPS [59,60], polymyxin MIC
decreased from 128 mg/L to 2 mg/L (Table 1).
All the IMI-S and IMI-I/R-resistant isolates harboured the
broad-spectrum b-lactamase TEM-24 and AmpC-enzyme. For
AmpC, no signiﬁcant variation was detected between the
MICs obtained with E-tests and those obtained by the dilution
method. The decrease in ceftazidime MICs with cloxacillin
conﬁrmed the over-production of AmpC (data not shown).
None of the tested qnr genes were detected. GyrA (Ile83-
Ser, numbering according to E. coli) and ParC (Ser80Ile)
modiﬁcations were identiﬁed in all the isolates supporting
the signiﬁcant quinolone MICs in addition to PAbN-sensitive
efﬂux.
Membrane transporters: detection of pump components
and outer membrane proteins
The signals obtained from RT-PCR analysis did not systemati-
cally correlate with the functional assembly of bacterial mem-
brane proteins [13]. Consequently, the analyses were carried
out by staining the membrane protein fractions and by per-
forming western blot analysis [13,14].
For IMI-S isolates, as indicated in Table 2 and Fig. 1 for
the strains of patient E, the AcrA and TolC signal observed
was slightly higher than that of the reference strain ATCC
13048. Outer membrane proteins OmpA and OmpX were
detected at the same expression level (Table 2). For Omp35
and Omp36, all IMI-S isolates exhibited a positive signal
(Table 2).
For IMI-I/R strains, an increased level of AcrA and TolC,
similar to that of strain EA27, was observed in all strains
except for strain NEA736500SCR (Patient E). This isolate
exhibited the highest signal for TolC (Fig. 1 and Table 2). No
change of OmpA and OmpX expression level was detected
(Table 2). For the Omp35 signal three proﬁles can be
observed: (i) an Omp35 expression in IMI-I strains for which
IMI MICs were 4–8 mg/L (n = 4); (ii) a decreased Omp35
level and the emergence of a new band for NEA736500BCR
for strains having an IMI MIC 16 mg/L (n = 1); and (iii) no
expression of Omp35 in IMI-R strains, IMI MICs between
16–32 mg/L (n = 3). Similar results were obtained with
TABLE 2. Evolution of outer membrane protein, efﬂux pump components, LPS and bacterial growth for the different E. aerog-
enes strains isolated at baseline and during the imipenem treatment period
Patient Strain AcrA TolC OmpA OmpX Omp36 Omp35 OmpA-like LPS Bacterial growth: OD600 nm at 24 h
A NEA39541S + ++ ++ + ++ ++ ) ) ‡2
NEA354871I ++ ++ ++ + ++ + ) ) ‡2
B NEA567234S + ++ ++ + ++ ++ ) ) ‡2
NEA575169I ++ ++ ++ + ++ ++ ) ) ‡2
C NEA31004S + ++ ++ + ++ ++ ) ) ‡2
NEA23214R ++ +++ ++ + ) ) ) ) ‡2
D NEA48271S + + ++ + ++ ++ ) ) ‡2
NEA51351I ++ + ++ + ++ + ) ) ‡2
E NEA43735R ++ ++ ++ + ) ) ) ) ‡2
NEA709472S + + ++ + ++ ++ ) ) ‡2
NEA734521I + ++ ++ + ++ ++ ) ) ‡2
NEA736500BCR ++ ++ ++ + + + + ) ‡2
NEA736500SCR ++ +++ ++ ++ ) ) ) ++ 1.110
ATCC13048 + + + + + + ) ) ‡2
EA27 ++ ++ ++ ++ ) ) ) ) ‡2
For Omp proteins, )corresponds to absence of signal, + to a slight and ++ to a high porin expression. For AcrA and TolC, )corresponds to absence of signal, + to a basal
level (ATCC strain) and ++ to a high efﬂux pump expression.
For LPS, )corresponds to PMB-susceptible strains (no LPS alteration), ++ to PMB-resistant strains (a high LPS alteration). For bacterial growth, +/) corresponds to a very
slow bacterial growth and ++ to a normal bacterial growth.
S, susceptible; I, intermediate susceptible; R, resistant.
FIG. 1 Detection of porins and efﬂux pump components in
E. aerogenes strains isolated in Patient E. Lane 1, ATCC13048;
lane 2–5, strains NEA709472S, NEA734521I, NEA736500BCR and
NEA736500SCR. A, Omp35 proﬁle; B, Omp36 proﬁle; C, AcrA
proﬁle; D, TolC proﬁle.
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antibodies directed against Omp36 (Table 2). The new band,
observed in isolate NEA736500BCR, was identiﬁed by mass
spectrometry to an OmpA-like protein.
Virulence of E. aerogenes isolates and bacterial growth
The HPI virulence factor-encoding genes were detected in all
isolates. The C. elegans model is well described for the study
of bacterial factors involved in infection and colonization
[26,27]. In the nematode killing assay, all IMI-S E. aerogenes
isolates were signiﬁcantly more virulent (LT50 3.5–
4.3 ± 0.5 days; LT100 7.8–8.3 ± 0.9 days) than both IMI-I
and IMI-R isolates (LT50 5.1–6.9 ± 0.8 days; LT100 10.3–
13.5 ± 0.7 days) (p <0.001) (Table 3). The IMI-I isolates were
signiﬁcantly more virulent than the IMI-R isolates (LT100
10.3–10.8 ± 0.8 days vs. 12.0–13.5 ± 0.9 days, respectively)
(p <0.001). The IMI-S isolates presented a similar level of vir-
ulence to strain ATCC13048 (LT100ATCC13048
8.4 ± 0.6 days). Strain NECS736500SCR, which displayed no
virulence, similarly to the avirulent E. coli OP50 strain
(Table 3), was signiﬁcantly less virulent than other tested
IMI-R isolates.
As shown in Table 2, the bacteria had a similar in vitro
growth independently of the IMI susceptibility phenotype
except for one strain, NEA736500scR, presenting a very slow
growth curve (data not shown). For the later strain, small
colonies were observed on agar medium and IMI and poly-
mixin B MICs were the highest for this isolate (Table 1). The
number of E. aerogenes CFU within the nematode gut varied
around 106 bacteria per worm for each strain 72 h after
ingestion without statistical difference (Table 4), conﬁrming
the presence of E. aerogenes isolates in the C. elegans intes-
tine.
Discussion
This study describes for the ﬁrst time a link between (i) the
alteration of E. aerogenes membrane physiology and the
impact of this on antibiotic susceptibility and (ii) the coloniza-
tion capability of E. aerogenes in the nematodes.
Various changes in the membrane of E. aerogenes isolates
were observed during the antibiotic treatment of patient E and
we scrutinized the bacterial evolution following three main
stages. In the ﬁrst stage, the isolate presented a resistance to
b-lactams (due to enzymatic expression) associated with resis-
tance to other antibiotic families, notably to ﬂuoroquinolones
(efﬂux pump and topoisomerase mutations). In the second
stage, the isolate became less susceptible to imipenem and
exhibited membrane modiﬁcations with a decrease in porin
TABLE 3. In vivo kinetics of killing of C. elegans infected by E. aerogenes strains (Str). Comparison of LT50 and LT100 between
the different strains tested. The results are representative of at least six independent trials for each group of strains. E. coli
OP50, E. aerogenes ATCC13048 and CM64 represent control strains
Patients Strains LT50 LT100
P
S vs. I S vs. R I vs. R Str vs. CM64 Str vs. OP50 Str vs. ATCC
A NEA39541S 3.5 ± 0.5 7.8 ± 0.8 – <0.001 – – <0.001 NS
NEA354871R 6.0 ± 0.2 12.0 ± 0.5 – <0.001 – <0.001 <0.001 <0.001
B NEA567234S 4.2 ± 0.2 8.3 ± 0.7 <0.001 – – <0.001 <0.001 NS
NEA575169I 5.1 ± 0.3 10.3 ± 0.7 <0.001 – – <0.001 <0.001 <0.001
C NEA31004S 4.3 ± 0.3 8.3 ± 0.7 – <0.001 – <0.001 <0.001 NS
NEA23214R 6.6 ± 0.4 12.3 ± 0.7 – <0.001 – <0.001 <0.001 <0.001
D NEA48271S 4.0 ± 0.2 8.0 ± 0.5 <0.001 <0.001 – <0.001 <0.001 NS
NEA51351I 5.4 ± 0.4 10.8 ± 0.8 <0.001 – <0.001 <0.001 <0.001 <0.001
NEA43735R 7.1 ± 0.2 12.4 ± 0.4 – <0.001 <0.001 <0.001 <0.001 <0.001
E NEA709472S 4.1 ± 0.3 8.0 ± 0.5 <0.001 <0.001 – <0.001 <0.001 NS
NEA734521I 5.2 ± 0.2 10.8 ± 0.8 <0.001 – <0.001 <0.001 <0.001 <0.001
NEA736500BCR 6.5 ± 0.5 12.1 ± 0.9 – <0.001 <0.001 <0.001 <0.001 <0.001
NEA736500SCR 6.9 ± 0.2 13.5 ± 0.5 – <0.001 <0.001 <0.001 NS <0.001
Reference strains OP50 8.6 ± 0.3 14.0 ± 0.5 ND ND ND <0.001 ND <0.001
CM64 3.2 ± 0.2 6.4 ± 0.6 ND ND ND ND <0.001 <0.001
ATCC13048 4.4 ± 0.2 8.4 ± 0.6 ND ND ND <0.001 <0.001 ND
ND, not determined; NS, not signiﬁcant; S, susceptible to imipenem; I, intermediately susceptible to imipenem; R, resistant to imipenem.
TABLE 4. Evaluation of CFU of clinical isolates and control
strains within the C. elegans digestive tract
Patients Strain Median CFU [range]/
nematode after 72 h
A NEA39541S 1.5 · 106 [0.9–1.7 · 106]
NEA354871I 2.9 · 106 [2.1–3.4 · 106]
B NEA567234S 1.2 · 106 [0.9–2.0 · 106]
NEA575169I 0.5 · 106 [0.2–1.0 · 106]
C NEA31004S 1.1 · 106 [0.5–1.5 · 106]
NEA23214R 5.2 · 106 [4.0–5.7 · 106]
D NEA48271S 7.1 · 106 [6.2–8.2 · 106]
NEA51351I 2.1 · 106 [1.8–2.6 · 106]
NEA43735R 3.8 · 106 [3.0–4.5 · 106]
E NEA709472S 5.1 · 106 [4.4–6.0 · 106]
NEA734521I 2.3 · 106 [1.6–3.1 · 106]
NEA736500BCR 4.2 · 106 [3.8–4.5 · 106]
NEA736500SCR 1.3 · 106 [0.6–1.5 · 106]
Reference strains ATCC 13048 2.7 · 106 [1.8–3.5 · 106]
CM64 4.3 · 106 [2.9–5.1 · 106]
CM64, ATCC 13048 derivative exhibiting an active efﬂux.
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production and over-expression of efﬂux pumps. In the third
stage, the isolate was resistant to imipenem and presented an
over-expression of efﬂux pumps conjointly with loss of the
main porins, and an alteration of LPS. The complete loss of the
two major porins and the LPS alteration were clearly involved
in strains exhibiting a high level of resistance to imipenem and
polymyxin as previously suggested [5,6].
These results indicate a strong modiﬁcation of the organi-
zation and physiology of the outer membrane that has a
direct impact on the bacterial ﬁtness. Indeed, the
NEC736500SCR isolate exhibiting polymyxin resistance, pre-
sented a slow growth with loss of porins and a maintained
over-expression of efﬂux pumps. The strain severely restricts
the membrane permeability, preventing any entry (e.g. antibi-
otics, nutrients that use the porin way), and its ﬁtness slows
down subsequently so that it only maintains elements provid-
ing bacterial survival [28].
Only a very few studies assess the virulence of MDR bac-
teria collected during antibiotic treatment and exhibiting vari-
ous levels of susceptibility. We reported here that the MDR
strains presenting the highest level of resistance to IMI-CHL-
OFL-FEP were signiﬁcantly less virulent than other strains.
The AmpC-producing and BSC-producing isolates collected
during the ﬁrst stage were as virulent as strain ATCC
13048, suggesting that b-lactamase expression and bacterial
virulence are non-overlapping mechanisms. An increased vir-
ulence is observed in strains harbouring an active efﬂux
pump as previously reported [29,30]. The expression of
RND efﬂux pump like AcrAB-TolC is a prerequisite in the
early bacterial colonization step to pass the bile salt barrier
or defensin activity [8,9,29,30]. Lastly, an abolished virulence
in strains presenting simultaneously a loss of porins and LPS
alterations is reported.
In the C. elegans model, the reduction of E. aerogenes viru-
lence is associated with the membrane modiﬁcations
involved in drug resistance. The combination of outer mem-
brane alterations induces an important decrease in bacterial
ﬁtness and adaptation to environmental stresses. Porin and
LPS organizations contribute to the physiological state
involved in the mid-late/late steps of host colonization
[9,11,12]. Consequently, porin deﬁciency and LPS modiﬁca-
tions selected during antibiotic pressure generate a non-
physiological membrane state with a ﬁtness cost that
decreases the bacterial capability for infection/colonization.
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